Swiss Electrical Stock News

Why the 2026 ESC Congress Matters for Novartis Stock Novartis (SWX:NOVN) is back in focus after confirming plans to present data from 10 cardiovascular studies at the 2026 European Society of Cardiology Congress, including late breaking Leqvio and abelacimab results. See our latest analysis for Novartis. At a share price of CHF127.42, Novartis has shown firm momentum, with a 7 day share price return of 4.07%, a year to date share price return of 17.44%, and a 5 year total shareholder return...

With investors questioning the reliability of US Treasuries and the dollar at the same time, attention is drifting toward markets that feel calmer and more predictable. That shift can create openings and risks in stocks linked to Swiss and other safe haven currencies, as clients reconsider where they hold their cash and portfolios. This article walks through three stocks exposed to that story and explains how the current backdrop could matter for each one. The sample of stocks covered below...

VZ Holding (SWX:VZN) is back in focus after reporting half year 2026 earnings on 14 August. Net income reached CHF 131.69 million, with basic earnings per share from continuing operations at CHF 3.34. See our latest analysis for VZ Holding. The earnings release appears to have supported momentum in VZ Holding’s share price, with a 30 day share price return of 8.68% and a 90 day share price return of 18.54%. Over a longer period, the 5 year total shareholder return of 120.71% contrasts with a...

It's been a good week for Geberit AG ( VTX:GEBN ) shareholders, because the company has just released its latest...

Shareholders might have noticed that Straumann Holding AG ( VTX:STMN ) filed its interim result this time last week...

Emmi AG ( VTX:EMMN ) shareholders are probably feeling a little disappointed, since its shares fell 5.0% to CHF825 in...

Temenos (SWX:TEMN) has announced a share repurchase program of up to CHF 100 million, authorized by its Board on 12 August 2026 and running until late February 2027, primarily for general corporate uses. See our latest analysis for Temenos. At a latest share price of CHF 74.40, Temenos has seen a 30 day share price return of 11.54% and a 1 year total shareholder return of 5.84%, while the 5 year total shareholder return remains down 43.41%. This suggests that recent momentum has improved from...

Sandoz Group (SWX:SDZ) is back in focus after the company agreed a collaboration with Shanghai Henlius Biotech to develop, manufacture and commercialise up to 10 biosimilars, with milestone payments up to US$322 million. See our latest analysis for Sandoz Group. The collaboration news arrives as Sandoz Group trades at CHF73.84, with a 30 day share price return of 15.45% and a year to date share price return of 29.05%. Over the past year, total shareholder return of 48.82% indicates that...

Sensirion Holding shares closed at CHF78.90 on Friday after a choppy week that left the stock slightly lower over seven days but modestly higher over the past month. The market reaction feels cautious. The headline from these H1 numbers is clear. Profitability in the sensor business is tightening under the microscope. Revenue for the first half came in at CHF179.0m while basic earnings per share reached CHF1.21. The key development is in the trailing picture. Net profit margin on the last...

Swiss Prime Site entered this earnings day with a mixed recent record. The stock is roughly flat over the past week, slightly down over one and three months, and valued on a rich P/E of 25.2x compared with lower sector averages. That sets a high bar for any real estate earnings print. The headline this time is about cash generation, not accounting profit. Funds From Operations, the key profit yardstick for property investors, reached about CHF 333m over the last twelve months and FFO per...

Zug Estates Holding went into this earnings day with a flat 7 day return and a share price around CHF 2,140 that had already cooled over the past month. The headline is not about rental income growth. It is about earnings quality. Reported net income sits at CHF 42.9m for the half year and the trailing figures still carry a CHF 26.8m one off gain that inflates profit margins. For you as an investor the key question now is how much of Zug Estates Holding’s rich P/E and premium to a discounted...

Roche Holding stock has delivered a 60.7% return over the past three years, and the recent run raises the question of whether the current price still lines up with what the valuation checks suggest. Over the past 3 years, Roche Holding has returned 60.7%, which puts recent gains front and centre in any assessment of what investors are now paying for the stock. Large ongoing investments in U.S. manufacturing capacity and diagnostics partnerships can support future cash generation. However,...

SIG Group AG recently appointed Ann-Kristin Erkens as CEO, replacing Mikko Keto, as its transformation programme delivered higher adjusted EBIT margins and stronger free cash flow, while the company reiterated its 2026 outlook and focus on aseptic system solutions. The planned Capital Markets Day in October, where SIG will outline its updated strategy and mid-term targets, gives investors a clearer lens on how the transformation programme could influence future business priorities and...

DKSH Holding (SWX:DKSH) is back in focus after its Malaysian unit reported a 34.8% year-on-year jump in second quarter net profit, supported by higher revenue and unrealised foreign exchange gains. See our latest analysis for DKSH Holding. At a share price of CHF66.40, DKSH Holding has seen its 30 day share price return of 3.75% and year to date share price return of 13.31%. The 1 year total shareholder return is 19.71%, which suggests momentum has been building rather than fading...

Sika (SWX:SIKA) has drawn fresh investor attention after issuing €1b in hybrid capital bonds split into two callable, subordinated tranches, while S&P shifted its issuer rating outlook on the company from Negative to Stable. See our latest analysis for Sika. For investors, the hybrid bond issuance and S&P outlook revision arrive as Sika’s share price shows renewed momentum, with a 30-day share price return of 17.92% and a 90-day gain of 25.14%, even though the 5-year total shareholder return...

Cosmo (SWX:CMHC) is back in focus after reporting 12 month Phase 3 data for its clascoterone 5% topical solution in male pattern hair loss, highlighting sustained efficacy and a safety profile comparable to vehicle. See our latest analysis for Cosmo. Despite the latest clascoterone update putting Cosmo back on investors’ radar, the stock has seen its share price fall 9.35% over the past month and 25.48% over the past quarter. At the same time, the 1 year total shareholder return of 7.43% and...

Landis+Gyr Group (SWX:LAND) recently expanded its Edge Application Ecosystem in Australia by adding Future Grid and Operational Technology Solutions as partners. For investors, this product move raises fresh questions about the stock’s positioning. See our latest analysis for Landis+Gyr Group. The Edge App Ecosystem update arrives after a mixed period for Landis+Gyr Group, with the share price at CHF46.85, a 30 day share price return of 6.96% but a year to date share price return that is down...

Why Basilea Pharmaceutica stock is back in focus Basilea Pharmaceutica (SWX:BSLN) is drawing fresh attention after reporting CHF 119 million in first half 2026 revenue and CHF 27.95 million in net income, along with higher full year guidance for both total revenue and operating profit. See our latest analysis for Basilea Pharmaceutica. The latest earnings and raised guidance have been met with a sharp shift in sentiment. Basilea Pharmaceutica’s share price return is 23.1% over 90 days and the...

Novavest Real Estate stock closed at CHF39.00 on 20 August, roughly flat over the past week and down over the last quarter, even as the latest half year numbers landed with very strong profitability. The headline is the margin story. Net profit margin over the past twelve months reached 76%, supported by a CHF9.5m one off gain that lifts the optics of earnings far above the underlying trend. For you as an investor, this is a classic time horizon test. The short term readout looks impressive...

Banque Cantonale Vaudoise came into this earnings day priced for perfection, trading on a rich 24.3x P/E and carrying a 3.62% dividend yield, yet the stock has drifted over the past month. The headline today is that profitability is being gently squeezed. Trailing net profit margin sits at 37.4%, slightly lower than the prior year, while risk weighted assets are climbing in step with mortgage and loan growth. For a bank already valued above Swiss and European peers, this margin pressure is...

Last week saw the newest half-yearly earnings release from PSP Swiss Property AG ( VTX:PSPN ), an important milestone...

Barclays is once again reshaping its investment bank, cutting leadership, tightening capital and leaning harder on its markets division. That shift could leave more room for UK and European retail and wealth focused banks that rely on simpler deposit and lending models rather than capital intensive trading and dealmaking. This article walks through three stocks exposed to that story and explains how the recent shake up might matter for your portfolio decisions. The three stocks covered below...

Banque Cantonale Vaudoise (SWX:BCVN) reported half year earnings to June 30, 2026, with net interest income of CHF 264.9 million and net income of CHF 225 million. This information can reshape how investors assess the stock. See our latest analysis for Banque Cantonale Vaudoise. The latest half year results arrive after a mixed few weeks in the market for Banque Cantonale Vaudoise, with the share price down 4.9% over the past month but still showing a 17.6% year to date share price return and...

Elma Electronic stock closed at CHF1,320 on Thursday, barely moved over the past week, while the latest earnings tell a much harsher story. The company booked a loss of CHF1.8 million for the first half of 2026 on revenue of CHF77.7 million, turning recent profit into red ink. In the short term, that profit squeeze and weak interest coverage frame the risk. Over a multi year lens, the bigger question is how long investors will keep paying about 1.9x sales for an unprofitable industrial...